Note 15 - Fair Value Disclosures (Tables)

6 Months Ended

Jun. 30, 2022

Notes Tables

Fair Value, by Balance Sheet Grouping [Table Text Block]

	Fair Value Measured at Reporting Date Using
	Carrying Amount		Level 1		Level 2		Level 3		Fair Value
At June 30, 2022:
Cash and cash equivalents	$	66,046	$	-	$	66,046	$	-	$	66,046
Note receivable – CEN Biotech Ukraine, LLC – related party	$	44,859	$	-	$	-	$	44,859	$	44,859
Advances to CEN Biotech Ukraine, LLC - related party	$	1,299,328	$	-	$	-	$	1,299,328	$	1,299,328
Loans payable	$	1,688,793	$	-	$	-	$	1,688,793	$	1,688,793
Loans payable – related parties	$	2,701,641	$	-	$	-	$	-	$	-
Convertible notes payable	$	713,330	$	-	$	-	$	713,330	$	713,330
Convertible notes payable – related parties	$	162,639	$	-	$	-	$	-	$	-
CEBA loan payable	$	47,400	$	-	$	-	$	47,400	$	47,400

	Carrying Amount		Level 1		Level 2		Level 3		Fair Value
At December 31, 2020:
Cash and cash equivalents	$	193,198	$	-	$	193,198	$	-	$	193,198
Note receivable – CEN Biotech Ukraine, LLC – related party	$	44,859	$	-	$	-	$	44,859	$	44,859
Advances to CEN Biotech Ukraine, LLC - related party	$	1,299,328	$	-	$	-	$	1,299,328	$	1,299,328
Loans payable	$	1,688,793	$	-	$	-	$	1,688,793	$	1,688,793
Loans payable – related parties	$	2,701,641	$	-	$	-	$	-	$	-
Convertible notes payable	$	643,330	$	-	$	-	$	1,890,736	$	1,890,736
Convertible notes payable – related parties	$	162,639	$	-	$	-	$	-	$	-
CEBA loan payable	$	31,552	$	-	$	-	$	31,552	$	31,552